Fluor (FLR) Q1 2026 Earnings Transcript

Fluor reported Q1 adjusted EBITDA of $60 million and adjusted EPS of $0.14, both well below last year, but the quarter was heavily distorted by a $96 million LOGCAP legal charge and a $37 million mining charge. Management tightened full-year adjusted EBITDA guidance to $525 million-$560 million, reiterated $2.60-$2.80 adjusted EPS, and kept operating cash flow guidance at $300 million while highlighting $2.7 billion of new awards, a $25.7 billion backlog, and 11 million shares repurchased for more than $500 million. The company remains constructive on LNG, power, data centers, and Middle East/Venezuela opportunities, but geopolitical risk and project-specific execution issues keep the outlook mixed.

Analysis

FLR’s setup is less about current-quarter earnings power and more about backlog repricing. The mix is improving: new work is being signed at better economics than the inherited book, which means reported margins should lag for a few quarters but then inflect as front-end awards convert into execution. That creates a classic “quality over quantity” setup where headline EBITDA can look weak while the forward earnings base quietly improves; the market tends to underwrite the current run-rate too aggressively and miss the lagged benefit from a higher-margin intake mix.

The bigger second-order effect is capital allocation. Management has effectively de-risked the balance sheet by monetizing a non-core asset and using proceeds to both buy back stock and preserve optionality for targeted M&A. If they can hold EBITDA near guide while continuing to repurchase at this pace, per-share economics can improve faster than operating income, especially once G&A normalizes and the legal overhang becomes an appeal-driven timing issue rather than a cash drain.

The key risk is not the isolated project charges; it is conversion timing. The stock is now implicitly dependent on multiple large front-end opportunities turning into full EPC awards within the next 2-3 quarters, and that path is exposed to geopolitics, client FID delays, and contract terms in data centers. If the Middle East stays unsettled into late Q2, the true downside is not a one-off charge but a broader deferral of client capex decisions, which would push the growth story into 2027 and compress the multiple.

Contrarian view: the market may be too focused on the earnings miss and not enough on the fact that most of the portfolio is now structured to avoid the old fixed-price blowup risk. FLR is increasingly a call option on power, nuclear, LNG, and select minerals with a shrinking legacy drag. The setup favors patience rather than chasing momentum: if awards convert, the rerating can be sharp; if they don’t, downside should be cushioned by buybacks and improving cash generation.

Key Decisions for Investors

• Long FLR into weakness over the next 2-6 weeks; target a 12-18 month hold. Risk/reward is attractive if the market continues to discount the backlog quality inflection and share repurchases provide a floor.
• For event-driven exposure, buy FLR call spreads 3-6 months out rather than stock if you want leverage to award conversion. The catalyst window is the next two earnings prints, where front-end awards should begin to show up in backlog and guidance confidence.
• Pair trade: long FLR / short a higher-beta industrial with more execution risk and less capital return support (e.g., KBR) for 6-9 months. Thesis is FLR’s improving mix, asset-light balance sheet, and buybacks versus weaker per-share compounding elsewhere.
• Avoid shorting FLR outright into the next quarter. The downside is more likely to come from timing slippage than fundamental deterioration, and that typically resolves with a few large award announcements rather than permanent multiple compression.
• If you want cleaner exposure to the power/data-center theme, pair FLR long with a weaker pure-play infrastructure name rather than chasing WULF. FLR is better positioned to monetize the buildout because it can participate in power infrastructure with lower contract risk.